T1	Participants 191 371	49 patients with non-insulin-dependent diabetes mellitus, after 4 and 6 months of successive periods of treatment with insulin and oral hypoglycaemics (glibenclamide and metformin)
T2	Participants 505 539	the patients were on glibenclamide
